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Summary
Objective: To determine the time sequence of biochemical and structural events associated with, and hypothesized to underlie, age-associated
tensile weakening of macroscopically normal adult human articular cartilage of the knee.
Methods: Macroscopically normal human articular cartilage of the lateral and medial femoral condyles (LFC and MFC) from Young (21e39
yrs), Middle (40e59 yrs), and Old (60 yrs) age donors were analyzed for tensile properties, surface wear, and cell and matrix composition.
Results: Variations in tensile, compositional, and surface structural properties were indicative of early, intermediate, and late stages of age-
associated cartilage deterioration, occurring at an earlier age in the MFC than the LFC. Differences between Young and Middle age groups
(indicative of early-to-intermediate stage changes) included decreased mechanical function in the superﬁcial zone, with a loss of (or low) ten-
sile integrity, and surface wear, with faint striations and mild staining on the articular surface after application of India ink. Differences between
Middle and Old age groups (indicative of intermediate-to-late stage changes) included maintenance of moderate level biomechanical function,
a decrease in cellularity, and a decrease in matrix glycosaminoglycan content. Tissue ﬂuorescence increased steadily with age.
Conclusions: Many of these age-associated differences are identical to those regarded as pathological features of cartilage degeneration in
early osteoarthritis. These ﬁndings provide evidence for the roles of mechanical wear, cell death, and enzymatic degradation in mediating the
progression through successive and distinguishable stages of early cartilage deterioration.
ª 2007 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.





With aging, the tensile properties of macroscopically normal
adult human knee articular cartilage diminish markedly1,2.
In particular, tensile strength and stiffness in the superﬁcial
layer of human femoral condylar cartilage diminish by
w65% betweenw24 yrs of age andw90 yrs of age. In the
deeper layers of cartilage, tensile strength also decreases
with age in the adult, with strength values being w50% of
those of superﬁcial layer cartilage at the same ages. Such
age-related weakening of cartilage may predispose the
knee joint to development of pain, dysfunction, and the clas-
sical histopathological features of osteoarthritis (OA). How-
ever, it is unknown how the age-related biomechanical
changes vary between sites within the knee joint and what
the structural or compositional basis for these changes are.
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may be due to alterations in cellularity or matrix properties,
and reﬂect (1) consequences of cell death, (2) mechanical
wear at the surface, (3) degradation of extracellular matrix
components, or (4) modiﬁcation of the collagen network
through crosslinks. Mechanical weakening with age may
arise from cell death and reﬂect an inability of the remain-
ing cells to synthesize and remodel matrix components to
maintain tissue homeostasis. However, whether cartilage
undergoes an age-associated decrease in cellularity is
controversial. The cell density, as determined from cell
counting in histological sections, of macroscopically nor-
mal human articular cartilage of the femoral condyles
has been shown to decrease with age1,2, but this may
be dependent on anatomical location and depth from the
articular surface3. Further, it is unclear if this decrease in
cellularity is due to cell death or if the presence of empty
lacunae is due to cell loss during histological preparation4.
Alternatively, cartilage weakening may relate directly to
mechanical wear5, with both cartilage weakening and
mechanical wear being a manifestation of disruption of
the collagen network, especially at or near the articular
surface6. In addition, mechanical weakening may be
due to degradation of extracellular matrix components.2
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tory cytokines and proteases7,8 may cause cleavage and
denaturation of the collagen network9,10, fragmentation
and loss of proteoglycans11,12, and tissue weakening.
However, these may be manifestations of more advanced
stages of osteoarthritic degeneration. Finally, modiﬁcations
to the collagen network such as the accumulation with age
of products of non-enzymatic glycation, including pentosi-
dine13,14, have been associated with a decrease in instan-
taneous deformation and increased collagen stiffening13.
This could give rise to a more brittle and fragile collagen
network and contribute to age-associated tensile weaken-
ing15. These four postulated mechanisms of biomechanical
weakening with age may, alone or in combination, underlie
progressive cartilage degeneration and, ultimately, end-
stage OA.
The site-speciﬁc pattern and severity of changes in car-
tilage properties in the knee joint may give insight into
the mechanism of age-related cartilage weakening. The
compositional, structural, and functional properties of ar-
ticular cartilage appear to be modulated by the extent
and pattern of joint loading across the knee joint. Areas
of high weight-bearing are associated with a relatively
high concentration of aggrecanase cleavage products16
and low equilibrium tensile modulus17 compared to areas
loaded more intermittently. In addition, the medial com-
partment of the knee is subjected to higher joint forces
than the lateral compartment during the stance phase
of normal gait18,19. This loading pattern may cause early
degenerative changes to be more prevalent in the medial
femoral condyle (MFC) than the lateral femoral condyle
(LFC)20. When degenerative changes are present, they
are usually more severe in the MFC than the LFC21 and
include a decrease in cartilage thickness of the MFC, but
not the LFC of patients with knee OA22. Functionally, the
cartilage of the MFC also has a lower indentation stiffness
than that of the LFC23,24. Overall cartilage function, composi-
tion, and structure appear to change progressively in early
degeneration and OA10,17,25,26. Thus, comparison of the
MFC and LFC cartilage with respect to age-associated
differences in the function, composition, and structure may
provide insight into the mechanisms of age- and OA dis-
ease-associated degeneration.
The hypothesis underlying this study was that human
articular cartilage, devoid of gross erosion, exhibits tensile
softening with age in a site-associated manner due to
changes in composition and structure, reﬂecting sequen-
tial stages of early cartilage degeneration. As a ﬁrst step
to test a causal link between speciﬁc changes and biome-
chanical weakening, this study sought to establish the ex-
tent of variations in the relevant properties of individual
human tissue samples that were macroscopically normal
with age. Once principal age-associated changes are es-
tablished, further study with experimentally controlled
manipulations of those properties could test the role of
speciﬁc processes as a pathogenic mechanism resulting
in cartilage degeneration. Thus, the objectives were to an-
alyze, in macroscopically normal and structurally charac-
terized human articular cartilage from adults of young,
middle, and old age and taken from different depths at
the LFC and MFC sites, (1) tensile biomechanical proper-
ties, (2) density of cells, (3) content of extracellular matrix
components, and (4) ﬂuorescence indicative of non-
enzymatic glycation products. The results were interpreted
in terms of the mechanisms of cartilage weakening, as
postulated above, and early, intermediate, and late adult
stages of age-associated degeneration.Materials and methods
SAMPLE SELECTION AND PREPARATION
Samples were selected from 31 human cadaveric donors
distributed among three adult age groups, Young (20e39
yrs), Middle (40e59 yrs), and Old (60 yrs). Donor tissue
was obtained from tissue banks with donation areas in the
Western and Southern areas of the United States. Donors
were excluded if they had a history of knee arthritis or if
the cause of death was due to a high velocity impact that
might cause acute knee injury. Donor joints were excluded
either if osteophytes were present or if subchondral bone
was exposed by cartilage erosion in the femoral
compartment.
Samples used for the present study were the normal sub-
sets of samples used, in part, in a previous study on inden-
tation stiffness and structural indices of wear23. These
samples were considered normal because, at harvest,
they were devoid of macroscopic cartilage erosion or visible
unevenness or granularity of the articular surface. Opposing
tibial surfaces displayed mild degeneration or small defects
(area of 0.13 0.06 cm2, mean SD, range of 0e0.2 cm2).
Samples were from the anterior region of the MFC (n¼ 28)
and LFC (n¼ 28) approximately 1.5 cm lateral or medial to
the intercondylar notch. The anterior region of each condyle
was selected for study because it exhibits moderate degen-
erative changes in the articular surfaces during aging20. In
addition, this region is relatively ﬂat27,28 and facilitates ten-
sile mechanical testing. The samples were from donors
who were distributed approximately evenly between males
(n¼ 4e7) and females (n¼ 3e5) within each age group. Al-
though donors were not selected based on body mass in-
dex (BMI), BMI was similar between age groups (ANOVA
P¼ 0.3, Table I).
In the prior study, parts of these samples were examined
for cartilage thickness, histopathology (MankineShapiro
score, surface irregularity), and surface roughening (reﬂec-
tance score after India ink staining). Cartilage thickness
[Fig. 1(A)] did not vary with age group and did not vary
with medial or lateral locations, consistent with the selection
of non-eroded cartilage specimens. The reﬂectance score
decreased with age group, indicating more ink staining,
and was lower in MFC samples compared to those of the
LFC [Fig. 1(B)]. In addition, the variance of the reﬂectance
score indicated more variation in ink staining with age in
the LFC and high variation in all age groups of the MFC
[Fig. 1(C)]. Consistent with this, the MankineShapiro histo-
pathology score29 of these normal samples, while being low
in general (e.g., compared to degenerate samples), in-
creased slightly in the MFC from Young to Old age groups
[Fig. 1(D)], primarily due to a higher surface irregularity
score [Fig. 1(E)]. Thus, while these samples were judged
to be macroscopically normal, there was evidence for very
mild age- and site-associated surface roughening at the
articular surface.
Samples were initially harvested in the form of 10-mm di-
ameter osteochondral cores with a notch placed in the pos-
terior-most edge of the core in order to maintain orientation.
Samples were soaked in an excess volume (w5 ml each) of
phosphate buffered saline (PBS) with proteinase inhibitors
(PI; 1 mM phenylmethylsulfonyl ﬂuoride, 2 mM ethylenedia-
minetetraacetic acid, 5 mM benzamidine hydrochloride, and
10 mM N-ethylmaleimide)30 at 4C for 1 h and then stored
at 70C until use. Samples were thawed in w1 ml of
PBS with PI for 15 min at room temperature prior to analy-
sis. Control studies with cartilage slices from Young and Old
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Donor description: age, BMI, and n of human female and male donors of osteochondral cores from the LFC and MFC reported as
mean S.E.M.
Lateral femoral condyle Medial femoral condyle
Young Middle Old Young Middle Old
Age (yr)
Female 33 2 47 3 73 5 33 2 47 3 70 2
Male 29 3 49 1 69 2 29 3 49 1 70 3
Femaleþmale 30 2 48 1 70 3 30 2 48 1 70 2
BMI (kg/m2)
Female 28 4 19 1 24 3 28 4 19 1 19 3
Male 25 1 24 2 24 1 25 1 24 2 24 1
Femaleþmale 26 2 23 1 24 2 26 2 23 1 22 2
n
Female 5 3 4 5 3 4
Male 4 6 6 4 7 5
Femaleþmale 9 9 10 9 10 9donors conﬁrmed that there was negligible loss of glycos-
aminoglycan (GAG) or DNA into the PBSþ PI bath solution
(<3% of the total).
BIOMECHANICAL PROPERTIES
Portions of each core were separated into superﬁcial,
middle, and deep layers and analyzed by tensile testing.
The cartilage of each core was sliced into w0.3-mm-thick
layers, at a distance from the articular surface of 0% (super-
ﬁcial layer, including the articular surface), 30% (middle
layer), and 60% (deep layer) of the average cartilage thick-
ness. These slices were cut into tapered specimens, with
a 0.8-mm-wide and 4-mm-long gage region oriented parallel
to the splitline pattern, for tensile testing using a methodol-
ogy31 that is a combination of previous equilibrium and con-
stant strain-rate test protocols17,32. Each tapered specimen
was elongated to 10 and 20% strains at 0.25%/s and al-
lowed to stress relax to equilibrium at each strain. This
was then followed by elongation of the specimen at a con-
stant rate of 5 mm/min until failure. The force data were nor-
malized to the width and thickness of the sample to obtain
stress in units of megapascals (MPa), and the displacement
data were normalized to the initial length to obtain strain (di-
mensionless). The equilibrium test results were analyzed to
determine tensile equilibrium modulus, and the dynamic
test results were used to assess tensile ramp modulus, ten-
sile strength, and failure strain.
BIOCHEMICAL PROPERTIES
Portions of tissue slices, adjacent to tensile samples,
were analyzed for cell and matrix properties. These portions
were weighed wet, lyophilized, weighed dry, and solubilized
with proteinase K (ProK). The solubilized portions were
used to determine total DNA33, hydroxyproline34, and
GAG content35, as well as intrinsic ﬂuorescence at excita-
tion (Ex) and emission (Em) wavelengths corresponding
to maximum ﬂuorescence of pyridinoline (Ex 295/Em
395 nm36) and pentosidine (Ex 335/Em 385 nm37) cross-
links, consistent with peaks in ﬂuorescence maps33. DNA
was converted to cell number using a conversion factor of
7.3 pg DNA/human chondrocyte3. Hydroxyproline content
was converted to collagen (COL) content using 7.1 as
the mass ratio of collagen to hydroxyproline38. Sulfated
GAG content was calculated by comparison to knownconcentrations of shark chondroitin sulfate. The contents
of DNA, COL, and GAG were calculated as the mass nor-
malized to wet weight. Fluorescence data are reported as
a ratio of pentosidine-associated ﬂuorescence to pyridino-
line-associated ﬂuorescence, the latter of which is stable
with age13.
The residual portions of the cartilage sections were ana-
lyzed for denatured collagen exactly as described previ-
ously9. Brieﬂy, proteoglycan was extracted with guanidine
hydrochloride (Gnd), degraded collagen was extracted
with alpha-chymotrypsin (aCT), and the remaining tissue
was digested with ProK. As a positive control for detecting
denatured collagen, this analysis was also performed on
portions of full-thickness cartilage from the patellae of
a 56-yr-old human donor, with some portions analyzed
directly and other portions heated to 80C for 4 h in 0.1 M
sodium phosphate and PI to denature the collagen in
a controlled manner. The aCT and ProK solutions were an-
alyzed for COL as described above, and the percent of COL
in aCT (denatured) was calculated as that in aCT compared
to the sum in aCT and ProK solutions.
STATISTICS
The effect of age group on the various mechanical and
biochemical parameters was assessed using repeated
measures ANOVA with anatomical location (LFC or MFC)
and depth from the surface (superﬁcial, middle, or deep)
as repeated factors. When anatomical location was found
to have a signiﬁcant independent effect (P< 0.05) or a sig-
niﬁcant interactive effect with layer (P< 0.05), the locations
were analyzed separately. When age group or depth from
the articular surface had an effect (P< 0.05), planned com-
parisons were made between age groups at each depth or
between depths for each age group; when age group and
depth both had effects or had an interactive effect, planned
comparisons were only made for age groups at each depth.
Each of these planned comparisons was tested using a sig-
niﬁcance level a¼ 0.05 divided by the number of compari-
sons made for a group (e.g., a¼ 0.025 for comparisons of
Young vs Middle, Young vs Old, and Middle vs Old groups,
since Young, Middle, and Old groups are each used in two
comparisons)39. For results that were expressed as a ratio
or percentage, data were arcsine transformed to improve
normality prior to the above statistical analyses. All data
are reported as mean S.E.M.
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BIOMECHANICAL PROPERTIES
Variation of a number of tensile properties with age group
occurred in a manner that was dependent on sample ana-
tomical location (site) and depth from the articular surface
(Fig. 2). Ramp modulus [Fig. 2(B)], strength [Fig. 2(C)],
and failure strain [Fig. 2(D)] were lower in the MFC than
LFC (P< 0.005, P< 0.01, and P< 0.005, respectively),
and equilibrium modulus [Fig. 2(A)] showed a similar trend
(P¼ 0.2). Each of these tensile properties was depth-
dependent (each, P< 0.005), with the equilibrium modulus
being 167% higher, the ramp modulus being 176% higher,
the strength being 29% higher, and the failure strain being
Fig. 1. Structural and surface properties of human articular cartilage
from the LFC and MFC. Cartilage thickness (A), reﬂectance score
assessed after India ink staining (B), the variance of reﬂectance
score (C), overall histopathological index of cartilage degeneration
(D), and surface irregularity assessed by histopathological grading
(E) from donors of Young (21e39 yrs old), Middle (40e59 yrs old),
and Old (60 yrs old) age groups. n ¼ 8e12. *P < 0.05,
**P< 0.005 vs Young age samples.54% lower in the superﬁcial layer than the deep layer.
More speciﬁc age-associated differences are described be-
low, as a function of site and depth.
In the LFC, a number of tensile properties of superﬁcial,
middle, and deep layers varied with age in a manner sug-
gesting that the superﬁcial layer was affected earliest (by
Middle age), while the middle layer was affected later (by
Old age), with the deep layer not showing any age-related
variation. In the LFC, the tensile integrity of the superﬁcial
layer of the Young age group was higher than that of the
Middle and Old age groups. The equilibrium modulus
[Fig. 2(A)], ramp modulus [Fig. 2(B)], and strength
[Fig. 2(C)] of the superﬁcial layer were 21% (P¼ 0.2) and
30% (P¼ 0.06), 46% (P< 0.005) and 47% (P< 0.005),
and 35% (P< 0.005) and 39% (P< 0.005) lower, respec-
tively, in Middle and Old age samples than corresponding
values in Young age samples. In middle layer cartilage of
the LFC, the ramp modulus (P¼ 0.09), and strength
(P¼ 0.04) tended to be lower in the Old age group than
the Young age group. In the LFC, failure strain did not
vary between age groups in superﬁcial, middle, or deep
layers [P¼ 0.09e0.8, Fig. 2(D)].
In the MFC, a number of tensile properties showed a pat-
tern of variation distinctly different from that of the LFC; the
MFC showed relatively little variation with age and depth. In
the MFC, the tensile integrity of the superﬁcial layer was
relatively low in all age groups. In the superﬁcial, middle,
and deep layers, the equilibrium modulus [P¼ 0.3e0.9,
Fig. 2(A)], ramp modulus [P¼ 0.2e1.0, Fig. 2(B)] and
strength [P¼ 0.09e0.8, Fig. 2(C)] did not vary with age
group. The failure strain of the superﬁcial layer was higher
in Middle age samples [P< 0.025, Fig. 2(D)], but did not
vary with age in the middle or deep layer (P¼ 0.05e1.0).
Taken together, these results show a pattern of age-associ-
ated tensile weakening which occurs at an early age in the
LFC and evidence for a tissue that is already weak by a
Young age in the MFC.
BIOCHEMICAL PROPERTIES
Variation of a number of biochemical properties with age
group also occurred in a manner that was dependent on site
and depth from the surface (Fig. 3). Water content
[Fig. 3(A)], DNA [Fig. 3(B)], COL in aCT [Fig. 3(D)], and
GAG [Fig. 3(F)] tended to be higher (P< 0.05, P¼ 0.09,
P< 0.005, and P< 0.05, respectively), and COL
[Fig. 3(C)] and ﬂuorescence ratio [Fig. 3(E)] was lower in
the MFC than the LFC (P< 0.05 and P< 0.005, respec-
tively). There was a depth-dependence in DNA
(P< 0.005), COL in aCT (P< 0.005), ﬂuorescence ratio
(P< 0.005), and GAG (P< 0.005), but not water content
(P¼ 0.2) or COL (P¼ 0.5). In particular, DNA, COL in
aCT, and ﬂuorescence ratio were 180%, 29%, and 15%
higher, respectively, and GAG was 66% lower in the super-
ﬁcial layer than the deep layer. The controlled heating of pa-
tellar cartilage increased collagen denaturation from 8 1%
to 76 3%, conﬁrming the method of analysis of degraded
collagen and the effectiveness of aCT extraction. At partic-
ular sites and depths, there were notable age-associated
differences in these cartilage components, as described be-
low. Overall, deterioration of certain biochemical properties
appeared to occur at stages subsequent to the decrease of
tensile integrity noted above.
The water content indicated the absence of marked age-
associated swelling of cartilage of these three age groups
[Fig. 3(A)]. In the superﬁcial, middle, and deep layers, the
water content did not vary with age group in the LFC
1046 M. M. Temple et al.: Weakening of human cartilageFig. 2. Tensile biomechanical properties of samples described in Fig. 1. For specimens from the superﬁcial, middle, and deep layers, the
tensile equilibrium modulus (A), tensile ramp modulus (B), tensile strength (C), and failure strain (D) were determined from equilibrium and
then non-equilibrium failure testing of articular cartilage from Young (Y), Middle (M), and Old (O) age donors. n¼ 9e12. *P< 0.05,
**P< 0.005 vs Young age samples.(P¼ 0.2e1.0) or MFC (P¼ 0.3e1.0) and was w73% of the
wet weight.
The DNA content, a measure of cell density, of the MFC
superﬁcial layer varied with age, while that of the LFC su-
perﬁcial layer, and also of the middle and deep layers of
the MFC and LFC did not [Fig. 3(B)]. For DNA content, there
was an interactive effect of anatomical location and layer,
so the sites (LFC, MFC) were analyzed separately. In the
MFC, the DNA content of the superﬁcial layer of Young
age samples tended to be higher than that of both Middle
and Old age samples (by 30%, P¼ 0.05 and 34%,
P¼ 0.05, respectively). In the LFC, the DNA content of
the superﬁcial layer tended to decrease from Young to
Old age (by 10%, P¼ 0.3). These differences in DNA con-
tent occurred at a stage after tensile properties were weak(by Middle age in the MFC whereas tensile integrity was al-
ready low at a Young age, and by Old age in the LFC
whereas tensile properties diminished at the Middle age).
In the LFC and MFC, the DNA content of the middle and
deep layers was similar between age groups (P¼
0.1e1.0). Thus, the pattern of age-associated decrease in
cell density, indicated by decreases in DNA content, of the
superﬁcial layer was delayed relative to the age-associated
decrease in tensile integrity.
Age-associated changes in the collagen network were
manifest as an alteration of the ﬂuorescence ratio
[Fig. 3(E)], but not as an alteration of the total COL content
[Fig. 3(C)] or COL in aCT [Fig. 3(D)]. COL content and COL
in aCT in the superﬁcial, middle, and deep layers of the LFC
and MFC did not show any age-associated change
Fig. 3. Biochemical properties of human articular cartilage samples described in Fig. 1. Cartilage tissue adjacent to the mechanical test
specimens was analyzed for water content (A), DNA and calculated cell number (B), COL (C), COL in aCT (D), the ﬂuorescence ratio (E)
of pentosidine-associated ﬂuorescence (Ex 335/Em 385 nm) to pyridinoline-associated ﬂuorescence (Ex 295/Em 395 nm) and GAG (F).
DNA, COL, and GAG were each normalized to wet weight. n¼ 9e12. *P< 0.05, **P< 0.005 vs Young age samples. yyP< 0.005 vs Middle
age samples.
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showed an increase with age at each depth, with differ-
ences depending on the site. In the LFC superﬁcial layer,
the ﬂuorescence ratio was higher in the Old age group
than in the Young age group (by 79%, P< 0.005). The ﬂuo-
rescence ratio was also higher in the LFC middle layer (by
51%, P< 0.025, and by 74%, P< 0.01, respectively), and
tended to be higher in the LFC deep layer (by 26%,
P¼ 0.09, and by 53%, P< 0.025, respectively) in Middle
and Old age groups than in the Young age group. In the
MFC, the ﬂuorescence ratio in the superﬁcial layer tended
to be higher in Middle (by 30%, P¼ 0.05) and was higher
in Old (by 85%, P< 0.005) age samples than Young age
samples, but was not distinguishably different with age in
middle and deep layers (P¼ 0.08e0.7). Taken together,
these results indicated that although the content of collagen
and degradation products in these macroscopically normal
samples were indistinguishable in aging, there was an
age-associated increase in pentosidine-associated ﬂuores-
cence in the superﬁcial layers, subsequent to tensile weak-
ening by Middle age in the LFC and subsequent to the weak
tensile state at Young age in the MFC.
The GAG content showed age-associated differences
that were localized to the deep and middle layers, and not
evident in the superﬁcial layer [Fig. 3(F)]. In the LFC, the
GAG contents of the middle and deep layers tended to be
lower in the Old age groups than in the Young age group
(by 31%, P< 0.005 and 34%, P¼ 0.04, respectively) and
also lower in the Old age groups and Middle age groups
(by 25%, P¼ 0.2 and 31%, P< 0.005, respectively). In
the MFC, the GAG of the middle and deep layers tended
to be lower in the Old age group than in the Young age
group (P¼ 0.2, and P¼ 0.03, respectively). The pattern of
decrease in GAG content in the middle and deep layers
from Middle to Old age groups appeared subsequent to
the low levels of tensile integrity in the Young (LFC) or Mid-
dle (MFC) age groups.
Discussion
This study of macroscopically normal human articular
cartilage identiﬁed a pattern of age-associated changes in
biomechanical integrity, cellularity, content of matrix compo-
nents, and ﬂuorescence index of non-enzymatic glycation,
some of which appear related to structural indices of sur-
face wear. These changes were prominent in cartilage at
certain anatomical locations and depths. Changes of a sim-
ilar sequence generally occurred at an earlier age in the
MFC than in the LFC. The decrease in tensile integrity of
the superﬁcial layer (Fig. 2) and increase in surface wear
(Fig. 1) occurred from Young to Middle age groups in the
LFC samples while low tensile integrity of the superﬁcial
layer and surface wear were already evident in MFC sam-
ples at the Young age. This was followed by a decrease
in tissue cellularity in the superﬁcial layer [Young to Middle
in the MFC, Fig. 3(B)], increased ﬂuorescence [from Middle
to Old in all layers of the LFC and a trend from Middle to Old
in the superﬁcial layer of the MFC, Fig. 3(E)], and de-
creased GAG content of the deep layer [from Middle to
Old in the LFC and MFC, Fig. 3(F)]. These age-associated
changes appear to represent stages of mild cartilage de-
generation that may progress to, or predispose the joint
to, the development of OA.
Several factors may limit the interpretation of the results
of this study. Diet, lifestyle, and genetics of human donors
were not controlled for or analyzed. However, sampleswere chosen to minimize effects of such factors by choos-
ing approximately equal numbers of male and female do-
nors for each age group, and selecting macroscopically
normal, non-eroded cartilage samples; also, BMI was simi-
lar between age groups. The macroscopically normal sam-
ples of this study were obtained from donors without OA
because normal-appearing cartilage in OA joints are sub-
jected to elevated levels of matrix degrading enzymes40.
However, such exclusion of OA donor samples may have
selected for tissue properties that are present in non-OA
samples and protective against OA. The sample sites, the
anterior region of the MFC and LFC, provided a relatively
ﬂat region27,28 for analysis; however, age-related changes
vary with region in the knee joint, and in this region are typ-
ically less severe or delayed relative to those in the central
weight-bearing regions, as well as the patella and uncov-
ered area of the tibial plateau20. Finally, although 31 donors
were analyzed, the sample size limits the statistical power.
For certain variables of interest, such as the tensile ramp
modulus and strength, signiﬁcant differences were detected
for the sample size of n¼ 9e10 per group. However, for
other variables, such as equilibrium modulus, differences
between Young, Middle, and Old age groups would have
had to be w45% for detection, and higher than the
20e30% difference seen in this study. The analysis of hu-
man cartilage samples in discrete layers and a single orien-
tation was done to limit sources of variability in measures of
biomechanical and biochemical properties. Such an analy-
sis of cartilage layers was done at the expense of analysis
of the full thickness of tissue, although indentation analysis
of adjacent tissue was reported previously23. The standard-
ized sampling of layers may also affect the interpretation of
the results. Dimensions and orientation with respect to the
splitline pattern41 of tapered tensile test specimens were
uniform among samples in this study and chosen to be sim-
ilar to those of previous studies17,42 to allow for direct
comparisons.
The changes in tensile integrity, surface wear, and tissue
composition were suggestive of early, intermediate, and
late stages of age-associated deterioration occurring in
a zonal pattern (Fig. 4) at an earlier age in the MFC than
the LFC. Early-to-intermediate age-associated changes in-
cluded surface wear and decreased mechanical function
of the superﬁcial zone, demonstrated here by India ink
staining and histopathological indices of roughness as
well as loss of, or low, tensile biomechanical integrity.
This was followed by intermediate-to-late stage changes
by a decrease in cellularity in the superﬁcial zone and net
depletion of GAG in the deep zone. Many of these age-
associated degenerative changes are essentially identical
to those regarded as features of cartilage in early OA43.
With regard to these proposed stages of age-associated
articular cartilage deterioration, some differences between
the MFC and LFC locations were striking. There was
a greater amount of degeneration in medial than lateral
samples by Old age as indicated by the increased histopa-
thology score. Further, the reﬂectance scores of medial
samples were much lower than those of lateral samples, es-
pecially at Middle and Old ages, indicating an increase in
surface wear. Each of these would lead to the expectation
for more weakened tissue in the MFC, which was the
case. Features such as higher cellularity in the superﬁcial
layer and lower failure strain in middle and deep layers of
MFC samples compared to those of corresponding LFC
samples may indicate intrinsic differences between articular
cartilage of the MFC and LFC. Alternatively, rather than be-
ing an indicator of advanced stages of age-associated
1049Osteoarthritis and Cartilage Vol. 15, No. 9Fig. 4. Summary of cartilage changes at early, intermediate, and late stages of age-associated degeneration in particular zones. Changes
in superﬁcial tangential zone (STZ), middle zone (MZ), and deep zone (DZ) are noted by C, with parentheses signifying variable changes.
Depicted are changes in mechanical integrity (degree of gray shading), articular surface wear, alterations of chondrocyte density, increase in
intrinsic ﬂuorescence, and loss of GAG (G).changes, the low tensile integrity of the MFC at Young ages
may be indicative of a difference in LFC and MFC matura-
tion (age <21 yrs), due to differences in contact forces or
pressures44,45. In addition, differential contact with the me-
nisci between the LFC and MFC samples might cause
site variations in the contact area through which load is
transmitted and, therefore, alter the joint pressures experi-
enced at those sites46.
The observed mechanical weakening of the LFC was lo-
calized to the superﬁcial layer and coincided with changes
in articular surface structure, rather than changes in bio-
chemical or cellular composition. Tensile weakening at
that site occurred during early-to-intermediate stages
[from Young to Middle age groups, Fig. 2(B, C)] and paral-
leled the mild age-associated decreases in reﬂectance
score and notable age-associated increase in the variance,
an indicator of the roughness of the articular surface
[Fig. 1(B, C)]. Samples including the articular surface (top
of specimen at 0%) were used because of its importance
to the tensile properties of articular cartilage32, to overall
cartilage deformation during joint loading47, and to its sensi-
tivity to aging42 and degeneration17. The age-associated in-
crease in surface irregularity, detected by histology and
image analysis of ink-stained surfaces performed in our
prior study23, indicated that there were mild alterations of
the articular surface. How this structural alteration relates
to the presence and/or loss of molecular components of
the superﬁcial zone remains to be determined. Nonethe-
less, the results of this study indicate that mild disruptions
of the articular surface may be the structural basis for
age-associated tensile weakening.
The analysis of tensile integrity expanded upon results of
previous studies by assessing the effect of age at each site.
This allowed separation of the confounding effects of osteo-
arthritic degeneration, site, and age on tensile integrity,factors which typically are present because of the preva-
lence of OA at advanced age48 and because cartilage de-
generation occurs earlier in the MFC than the LFC20. The
range of values of tensile moduli and strength were gener-
ally similar to those obtained in previous studies of tensile
equilibrium17 and dynamic stiffness and failure42. The
age-associated decrease in tensile strength of w10% per
decade of age of macroscopically normal human articular
cartilage noted by Kempson42 would appear to represent,
based on the current study [Fig. 2(C)], the combination of
an age-associated decrease of tensile strength of the LFC
and low strength of the MFC at all ages. Furthermore, the
tensile weakening with age, in addition to changes with
degeneration and OA, noted by Akizuki et al.17 (middle-
age ﬁbrillated and old-age OA cartilage), with tensile
equilibrium moduli being w85% and 70% lower than those
of young normal cartilage, appears to be partially (w20%)
attributable to age-associated tensile weakening demon-
strated in this study [Fig. 2(A)]. Thus, both age and site
on the femoral condyle contribute markedly to variation in
cartilage tensile biomechanical properties.
The analysis of DNA content helps to clarify the contro-
versy about age-associated changes in cartilage cellularity
at different depths. Measures of DNA in macroscopically
normal human articular cartilage were made possible in
small portions of tissue by an assay of DNA33 that has im-
proved sensitivity and speciﬁcity49 over other assays50,51.
The measure of DNA in this study does indicate an age-
associated decrease in cellularity, localized to the MFC su-
perﬁcial layer [Fig. 3(B)]. This result parallels the decrease
of cell density as measured by cell counting in histological
sections, where cell density decreased with age in macro-
scopically normal articular cartilage from weight-bearing
zones after 40 yrs of age1,2, especially in the superﬁcial
zone3. It remains unclear if the decrease in cell density
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or if the presence of empty lacunae is due to a histological
artifact of cell loss4. The biochemical analyses support the
notion that the measured DNA is within cells, rather than
in the extracellular space, since tissue extracts with Gnd
and aCT (that remove 90% of GAG) contained virtually
no DNA (<2% of the total in the tissue, data not shown).
One caveat, however, is that the biochemical measure of
DNA does not describe cell activity or organization, and
focal sites of hypo- and hypercellularity may exist. The de-
crease in cell density in the superﬁcial zone of cartilage
may contribute to the inability of remaining cells to main-
tain extracellular matrix in this region, and, thus, to the
eventual deterioration and loss of mechanical integrity.
The constancy of total and denatured collagen content in
samples from different adult age groups is consistent with
and expands on the idea that collagen turnover is modest
in mature, macroscopically normal cartilage. The total colla-
gen content [Fig. 3(C)] and denatured collagen content
[Fig. 3(D)] agree with previously reported values9,10,52 and,
further, varied little with age or depth from the articular sur-
face. The low levels of collagen denaturation [2e4%,
Fig. 3(D)], and absence of marked site-associated varia-
tions, are consistent with the source of tissue, i.e., joints
undergoing normal aging rather than osteoarthritic degener-
ation, which typically exhibit extensive cartilage collagen de-
naturation (w10%)9,10. Taken together, these ﬁndings
suggest that the early age-related cartilage weakening,
prominent in the LFC superﬁcial layer [Fig. 2(B, C)], is un-
likely to be due to collagen denaturation, at least of the
extent present in OA and inﬂammatory arthritis; indeed,
both osteoarthritic cartilage and IL-1-treated cartilage ex-
plants exhibit tensile softening or weakening that is associ-
ated with markedly increased levels of denatured
collagen9,10,17,53.
The ﬂuorescence ratio may reﬂect cumulative effects of
matrix and collagen remodeling, which, in turn, affect carti-
lage tensile properties. The general age-associated in-
crease in ﬂuorescence ratio is consistent with the
accumulation of end products of non-enzymatic glyca-
tion13,14. Such glycation and increased ﬂuorescence have
been associated, on one hand, with increased stiffness
and lower collagen turnover54 that may be protective to car-
tilage; evidence for a protective effect are the increases in
ﬂuorescence ratio in the LFC superﬁcial layer from Middle
to Old age and in the MFC superﬁcial layer from Young to
Middle to Old age [Fig. 3(E)], during which times tensile
properties are maintained (Fig. 2). On the other hand, in-
creased glycation has been associated with increased
brittleness (lower failure strain) and/or lack of collagen re-
modeling that may precipitate weakening (lowered strength
and ramp modulus) of cartilage15; the absence of such
changes in tensile properties in this study suggests that gly-
cation does not have such detrimental effects. It should be
noted, however, that this measure of intrinsic ﬂuorescence
was an index of crosslink ﬂuorescence and that may be af-
fected by other matrix components.
The pattern of variation in GAG content with depth is
generally similar to that found in previous studies32,55,
but also showed an age-associated decrease of GAG con-
tent in the deep layer of articular cartilage [Fig. 3(F)]. The
measure of sulfated GAG, by reaction with DMMB, was
standardized to a chondroitin sulfate standard, and is in-
dicative of charge content since keratan sulfate (one an-
ionic charge group per disaccharide) gives half as much
signal per mass as does chondroitin sulfate (two anionic
charge groups per disaccharide)35. No attempt wasmade to assess speciﬁc alterations of GAG or aggrecan
structure that change with skeletal development and
aging56e59 and OA25. The decrease with age of GAG in
the deep layer from Middle to Old age [Fig. 2(F)] occurs
without additional elevation in ﬂuorescence [Fig. 2(G)],
suggesting that substantial turnover of both GAG and col-
lagen matrix is occurring. The localization in the deep layer
is intriguing, particularly given recent evidence that
changes in subchondral bone turnover can markedly affect
the overlying articular cartilage60e62.
More work is needed to fully elucidate the causes and
consequences of age-associated tensile weakening. The
results of this study point to a role for surface wear and fa-
tigue as major changes in early cartilage deterioration with
cell loss being a downstream event. Tensile weakening
may be directly related to wear at the articular surface5,6,
with disruption of the collagen network in areas within or ad-
jacent to striations. Consequences of this initial surface
wear may include further disruption of the collagen network,
loss of extracellular matrix molecules, and loss of cells. Ini-
tial age-associated tensile weakening appears not to be
due to enzyme-mediated degradation of the collagen net-
work and proteoglycan, or to an age-associated increase
in collagen crosslinking, because tensile weakening occurs
early at the articular surface, and occurs prior to the alter-
ation of these matrix components. Further study is needed
of joints with more advanced stages of degeneration to es-
tablish the sequence of events leading to the development
of OA. The extent and localization of changes in particular
tissue properties sets the stage for further studies with spe-
ciﬁc and graded manipulations to test the mechanistic rela-
tionship for the sequence of events described in Fig. 4.
Diminished tissue integrity, associated with aging in the
LFC, and with the MFC in general, appears to be an early
and sensitive marker of cartilage degeneration and may
causally contribute to degeneration and the development
of OA.
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